Key facts
- Aqua Heart’s last known valuation is $29.6M (Dec 2025).
- It has raised $8.3M across 2 recorded rounds; the latest was Seed Round ($1.6M) in Dec 2025.
- Aqua Heart has filed 1 Form D with the SEC, most recently Aug 2021 ($6.7M sold to 32 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·Watchlist + deal alerts for Aqua Heart
Funding rounds
2 roundsAbout Aqua Heart
Developer of a technology platform designed for democratizing heart ablation to treat atrial fibrillation. The company's platform uses high-energy, single-shot cardiac ablation catheter technology that dismisses the need for complicated mapping procedures while providing success feedback, enabling users to make treatment available on a large scale.
- Sector
- Healthcare
- HQ
- Santa Ana, CA, United States
- Founded
- 2018
- Employees
- 4
- Website
- aquahrt.com/
- Ownership
- Privately Held (backing)
Aqua Heart doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Aqua Heart shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Aqua Heart in its N-PORT filings yet. We sweep new filings monthly.